International Patent: AN AGENT THAT INCREASES NATO3 EXPRESSION AND/OR ACTIVITY FOR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS

GENEVA, Sept. 18 -- UNIVERSITÉ DE GENÈVE filed a patent application (EP2025/054412) for “AN AGENT THAT INCREASES NATO3 EXPRESSION AND/OR ACTIVITY FOR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS”. With publication no. WO/2025/176707, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: A61K 35/30

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....